Profound Medical Corp
TSX:PRN
Profound Medical Corp
TSX:PRN
Price:
10.84 CAD
-3.73%
Market Closed
Updated:
Apr 29, 2024
Section:
Relative Value
The Relative Value of one
PRN
stock under the Base Case scenario is
5.38
CAD.
Compared to the current market price of 10.84 CAD,
Profound Medical Corp
is
Overvalued by 50%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
PRN
Relative Value
Base Case
5.38
CAD
Overvaluation 50%
Valuation Multiples
Multiples Across Competitors
PRN Competitors Multiples
Profound Medical Corp Competitors
Profound Medical Corp Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CA |
|
Profound Medical Corp
TSX:PRN
|
264.8m CAD | 26.9 | -6.8 | -6.3 | -6 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
186.5B USD | 4.6 | 33.1 | 19.5 | 29 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
133.1B USD | 18.2 | 67 | 54.9 | 68.9 | |
| US |
|
Stryker Corp
NYSE:SYK
|
127.6B USD | 6.2 | 40.3 | 25.1 | 31.1 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
107.2B USD | 7.5 | 68.3 | 31.7 | 47.3 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
106B USD | 3.3 | 25.2 | 13.5 | 19.1 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
66.9B USD | 3.4 | 54.9 | 18.4 | 38.9 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
59.1B EUR | 2.8 | 38.9 | 18.6 | 31.4 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
52B USD | 8.7 | 37 | 26.8 | 29 | |
| CN |
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
364.8B CNY | 10.6 | 32.2 | 28 | 28 | |
| US |
|
Dexcom Inc
NASDAQ:DXCM
|
47.9B USD | 13.2 | 88.5 | 59.6 | 77.6 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
You don't have any saved screeners yet
